How to buy Medical Developments International (MVP) shares
Learn how to easily invest in Medical Developments International shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Medical Developments International Limited is a drug manufacturers-specialty & generic business based in Australia. Medical Developments International shares (MVP) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian Dollars. Medical Developments International has a trailing 12-month revenue of around $25.3 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Medical Developments International
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the Australian Securities Exchange (ASX). Our table below can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Medical Developments International . Find the share by name or ticker symbol: MVP. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Medical Developments International reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check in on your investment. Congratulations, you own a part of Medical Developments International . Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
- Medical Developments International key stats
- Compare share trading platforms
- Is Medical Developments International stock a buy or sell?
- Medical Developments International performance over time
- Medical Developments International 's financials
- How volatile are Medical Developments International shares?
- Does Medical Developments International pay a dividend?
- Other common questions
Medical Developments International stock price (ASX:MVP)Use our graph to track the performance of MVP stocks over time.
Medical Developments International shares at a glance
|52-week range||$3.21 - $7.29|
|50-day moving average||$4.0365|
|200-day moving average||$4.78|
|Dividend yield||$0 (0%)|
|Earnings per share (TTM)||$-0.184|
Compare share trading platforms
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Medical Developments International stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Medical Developments International price performance over time
|1 week (2021-09-17)||25.72%|
|1 month (2021-08-25)||34.10%|
|3 months (2021-06-25)||11.75%|
|6 months (2021-03-25)||0.58%|
|1 year (2020-09-25)||3.16%|
|2 years (2019-09-25)||7.17%|
|3 years (2018-09-25)||30.75%|
|5 years (2016-09-23)||-0.38%|
Is Medical Developments International under- or over-valued?
Valuing Medical Developments International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Medical Developments International 's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Medical Developments International 's EBITDA
Medical Developments International 's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $2.6 million (£0.0 million).
The EBITDA is a measure of a Medical Developments International 's overall financial performance and is widely used to measure a its profitability.
Medical Developments International financials
|Revenue TTM||$25.3 million|
|Gross profit TTM||$19.1 million|
|Return on assets TTM||-1.09%|
|Return on equity TTM||-22.51%|
|Market capitalisation||$372.7 million|
TTM: trailing 12 months
Medical Developments International share dividends
We're not expecting Medical Developments International to pay a dividend over the next 12 months.
Medical Developments International share price volatility
Over the last 12 months, Medical Developments International 's shares have ranged in value from as little as $3.21 up to $7.29. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (AU average) beta is 1, while Medical Developments International 's is 1.382. This would suggest that Medical Developments International 's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Medical Developments International overview
Medical Developments International Limited manufactures and distributes pharmaceutical and veterinary products, and medical devices. The company operates through three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management for use in home or in hospitals; Penthrox, a prescription only medicine for pain in trauma; and medical devices, such as CPR face shield key rings, CPR masks, finger pulse oximeters, flow meter regulators, MDI tourniquets, manually triggered ventilators, OXI port carry and hand bags, resuscitation kits, oxygen therapy masks, and resuscitators. The company also provides veterinary anaesthetic machines, including animal asthma chambers, animal silicone face masks, animal air cushion face masks, resuscitators, MDI tourniquets, vaporisers, animal anaesthetic machines, breathing monitors, autoclavable and disposable CO2 absorbers, and accessories for anaesthetic machines. It operates in Australia, Europe, North America, the Middle East, Asia, and South Africa. The company was incorporated in 2003 and is headquartered in Scoresby, Australia.
Stocks similar to Medical Developments International
Medical Developments International in the news
Bullish Medical Developments International Limited (ASX:MVP) insiders filled their treasuries with AU$2.8m worth of stock over last year
Frequently asked questions
More guides on Finder
How to invest in the Cosmos Exploration IPO
Everything we know about the Cosmos Exploration IPO, plus information on how to buy in.
What is behind the bounce in the Zip Co share price?
Shares in BNPL provider Zip Co have slipped more than 13% in the last 6 months.
Why the AGL share price has rebounded today
Shares in electricity giant AGL Energy are down 60% in the last 12 months.
How to invest in the Dundas Minerals IPO
Everything we know about the Dundas Minerals IPO, plus information on how to buy in.
How to invest in the Kalgoorlie Gold Mining IPO
Everything we know about the Kalgoorlie Gold Mining IPO, plus information on how to buy in.
The best iron ore stocks on the ASX (2021)
We look at some of the biggest and best performing iron ore stocks in Australia.
Why are the CBA and WBC share prices stumbling today?
Shares in the major banks have risen more than 50% in the last 12 months.
How to buy Evergrande shares from Australia
Steps to owning and managing China Evergrande Group shares from Australia.
How to invest in the Hamelin Gold IPO
Everything we know about the Hamelin Gold IPO, plus information on how to buy in.
How to invest in the Lykos Metals IPO
Everything we know about the Lykos Metals IPO, plus information on how to buy in.
Ask an Expert